Treatment of Anal Incontinence With Intersphincteric Implants
Launched by REGION SKANE · Mar 14, 2017
Trial Information
Current as of May 20, 2025
Terminated
Keywords
ClinConnect Summary
Treatment of anal incontinence (AI) remains a challenge - although conservative treatment can reduce the severity of many patients' AI, many continue to experience symptoms that severly affect their quality of life and ability to function properly both socially and professionally.
The level of AI is measured with the St Marks score (ranging from 0-24 where zero is complete continence).
Some patients with AI are shown to have defects in the anal sphincters (i.e. traumatic lesions post partum) and can be helped with reconstructive surgery. These procedures are effective but carry substantia...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subject has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent.
- • 2. Subject must be at least 18 years of age
- • 3. Subject must have a St Marks score of at least 11
- • 4. Subject must be able to comply with study and study follow-up requirements.
- Exclusion Criteria:
- • 1. Subjects with Crohn's disease or Ulcerative colitis
- • 2. Subject has (a history of) malignancy in the rectum or anal canal
- • 3. Subject has an ongoing treatment with chemotherapy (all indications)
- • 4. Subject has verified active anal fistula(e)
- • 5. Subject is unable or unwilling to provide informed consent.
About Region Skane
Region Skåne is a leading healthcare authority in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. Committed to fostering collaboration between researchers, healthcare professionals, and patients, Region Skåne aims to enhance the understanding of various health conditions and develop effective treatment strategies. With a focus on ethical standards and patient safety, the organization plays a pivotal role in shaping the future of healthcare in the region and beyond, ensuring that clinical trials are conducted with the highest level of scientific rigor and transparency.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malmo, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials